Long-term outcome of occupational asthma with different etiology.
Journal
Current opinion in allergy and clinical immunology
ISSN: 1473-6322
Titre abrégé: Curr Opin Allergy Clin Immunol
Pays: United States
ID NLM: 100936359
Informations de publication
Date de publication:
22 Dec 2023
22 Dec 2023
Historique:
medline:
21
12
2023
pubmed:
21
12
2023
entrez:
21
12
2023
Statut:
aheadofprint
Résumé
This review summarizes the recent literature on the long-term outcome of sensitizer-induced and irritant-induced occupational asthma. Recent studies of sensitizer-induced occupational asthma show that after the offending exposure has ceased, most patients report at least partial relief of symptoms. However, in the long term, the diagnosis may negatively impact their careers, incomes, and quality of life. The studies also offer new insights into diisocyanate-induced occupational asthma phenotypes and asthma remission rates. One third of these cases were in remission in long-term after reduction or cessation of exposure. The long-term prognosis of irritant-induced occupational asthma was demonstrated to be poorer than sensitizer-induced occupational asthma. Older age, low fractional exhaled nitric oxide levels and uncontrolled asthma at the time of diagnosis predicted uncontrolled asthma in the long term in patients with irritant and low-molecular-weight sensitizer induced occupational asthma. Recent studies provide further evidence of the long-term outcome of different occupational asthma phenotypes and the factors that affect them. These findings help us identify patients at risk of poor asthma outcomes, who need close monitoring and support. It should also be borne in mind that occupational asthma diagnosis may have wider-ranging negative impacts on patients' lives.
Identifiants
pubmed: 38126800
doi: 10.1097/ACI.0000000000000962
pii: 00130832-990000000-00099
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Barber CM, Cullinan P, Feary J, et al. British Thoracic Society Clinical Statement on occupational asthma. Thorax 2022; 77:433–442.
Tarlo SM, Vandenplas O, Bernstein DI, Malo JL. Tarlo SM, Vandenplas O, Bernstein DI, Malo JL. Definition and classification of asthma in the workplace. Asthma in the workplace CRC Press, 5th ed. Boca Raton:2022.
Cullinan P, Vandenplas O, Bernstein D. Assessment and management of occupational asthma. J Allergy Clin Immunol Pract 2020; 8:3264–3275.
Vandenplas O, Godet J, Hurdubaea L, et al. Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma? Allergy 2019; 74:261–272.
Lemiere C, Lavoie G, Doyen V, Vandenplas O. Irritant-induced asthma. J Allergy Clin Immunol Pract 2022; 10:2799–2806.
Lindström I, Lantto J, Karvala K, et al. Occupations and exposure events in acute and subacute irritant-induced asthma. Occup Environ Med 2021; 78:793–800.
Vandenplas O, Wiszniewska M, Raulf M, et al. EAACI position paper: irritant-induced asthma. Allergy 2014; 69:1141–1153.
Takeda N, Maghni K, Daigle S, et al. Long-term pathologic consequences of acute irritant-induced asthma. J Allergy Clin Immunol 2009; 124:975–981. e1.
Bernstein JA, Dumas O, de Blay F. Tarlo SM, Vandenplas O, Bernstein DI, Malo JL, et al. Irritant-induced asthma and reactive airways dysfunction syndrome. Asthma in the workplace CRC Press, 5th ed. Boca Raton:2022.
Henneberger PK, Patel JR, de Groene GJ, et al. Workplace interventions for treatment of occupational asthma. Cochrane Database Syst Rev 2019; 10:Cd006308.
Lemiere C, Forget A, Dufour MH, et al. Characteristics and medical resource use of asthmatic subjects with and without work-related asthma. J Allergy Clin Immunol 2007; 120:1354–1359.
Lemière C, Boulet LP, Chaboillez S, et al. Work-exacerbated asthma and occupational asthma: do they really differ? J Allergy Clin Immunol 2013; 131:704–710.
Lipszyc JC, Silverman F, Holness DL, et al. Comparison of psychological, quality of life, work-limitation, and socioeconomic status between patients with occupational asthma and work-exacerbated asthma. J Occup Environ Med 2017; 59:697–702.
Moullec G, Lavoie KL, Malo JL, et al. Long-term socioprofessional and psychological status in workers investigated for occupational asthma in Quebec. J Occup Environ Med 2013; 55:1052–1064.
Miedinger D, Lavoie KL, L’Archevêque J, et al. Identification of clinically significant psychological distress and psychiatric morbidity by examining quality of life in subjects with occupational asthma. Health Qual Life Outcomes 2011; 9:76.
Miedinger D, Lavoie KL, L’Archevêque J, et al. Quality-of-life, psychological, and cost outcomes 2 years after diagnosis of occupational asthma. J Occup Environ Med 2011; 53:231–238.
Maestrelli P, Schlünssen V, Mason P, Sigsgaard T. Contribution of host factors and workplace exposure to the outcome of occupational asthma. Eur Respir Rev 2012; 21:88–96.
Rachiotis G, Savani R, Brant A, et al. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007; 62:147–152.
Maghni K, Lemière C, Ghezzo H, et al. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004; 169:367–372.
Malo JL, Ghezzo H. Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am J Respir Crit Care Med 2004; 169:1304–1307.
Ortega HG, Kreiss K, Schill DP, Weissman DN. Fatal asthma from powdering shark cartilage and review of fatal occupational asthma literature. Am J Ind Med 2002; 42:50–54.
Wisnewski AV, Cooney R, Hodgson M, et al. Severe asthma and death in a worker using methylene diphenyl diisocyanate MDI asthma death. Am J Ind Med 2022; 65:166–172.
Rüegger M, Droste D, Hofmann M, et al. Diisocyanate-induced asthma in Switzerland: long-term course and patients’ self-assessment after a 12-year follow-up. J Occup Med Toxicol 2014; 9:21.
Piirilä PL, Nordman H, Keskinen HM, et al. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med 2000; 162 (2 Pt 1):516–522.
Ameille J, Pairon JC, Bayeux MC, et al. Consequences of occupational asthma on employment and financial status: a follow-up study. Eur Respir J 1997; 10:55–58.
Padoan M, Pozzato V, Simoni M, et al. Long-term follow-up of toluene diisocyanate-induced asthma. Eur Respir J 2003; 21:637–640.
Feary J, Cannon J, Fitzgerald B, et al. Follow-up survey of patients with occupational asthma. Occup Med (Lond) 2020; 70:231–234.
Mason P, Liviero F, Maestrelli P, Frigo AC. Long-term follow-up of cluster-based diisocyanate asthma phenotypes. J Allergy Clin Immunol Pract 2021; 9:3380–3386.
Mason P, Liviero F, Paccagnella ER, et al. Impact of occupational asthma on health and employment status: a long-term follow-up study. Occup Environ Med 2023; 80:70–76.
Bhérer L, Cushman R, Courteau JP, et al. Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: II. Follow up of affected workers by questionnaire, spirometry, and assessment of bronchial responsiveness 18 to 24 months after exposure ended. Occup Environ Med 1994; 51:225–228.
Malo JL, L’Archevêque J, Castellanos L, et al. Long-term outcomes of acute irritant-induced asthma. Am J Respir Crit Care Med 2009; 179:923–928.
Malo JL, Cartier A, L’Archeveque J, et al. Prevalence of occupational asthma among workers exposed to eastern white cedar. Am J Respir Crit Care Med 1994; 150 (6 Pt 1):1697–1701.
Aldrich TK, Weakley J, Dhar S, et al. Bronchial reactivity and lung function after world trade center exposure. Chest 2016; 150:1333–1340.
Lantto J, Suojalehto H, Karvala K, et al. Clinical characteristics of irritant-induced occupational asthma. J Allergy Clin Immunol Pract 2022; 10:1554–1561. e7.
Lantto J, Suojalehto H, Lindström I. Long-term outcome of occupational asthma from irritants and low-molecular-weight sensitizers. J Allergy Clin Immunol Pract 2023; 11:1224–1232. e2.